Key Events This Week
09 Feb: Stock hits 52-week low of Rs.24 amid ongoing weakness
11 Feb: Q3 FY26 results reveal deepening losses
12 Feb: New 52-week low of Rs.22.99 recorded
13 Feb: Further decline to 52-week low of Rs.22 amid continued downtrend
09 February 2026: Stock Hits 52-Week Low of Rs.24 Amidst Continued Weakness
On 09 Feb 2026, Medi Caps Ltd’s share price touched a fresh 52-week low of Rs.24, marking a significant downturn from its 52-week high of Rs.53.76. Despite this low, the stock showed some intraday resilience, reaching an intraday high of Rs.26.43, a gain of 8.63% from the opening price, suggesting a brief attempt at recovery. However, the overall trend remained negative as the stock closed with a modest gain of 0.70% at Rs.24.50.
This decline occurred amid broader market strength, with the Sensex gaining 1.04% to close at 37,113.23. The stock’s underperformance relative to the Sensex highlighted company-specific challenges, including weak financials and liquidity concerns. The stock remained below all key moving averages, signalling sustained downward pressure.
11 February 2026: Q3 FY26 Results Reveal Deepening Losses
Medi Caps Ltd reported its Q3 FY26 results on 11 Feb 2026, revealing a continuation of financial difficulties. The company posted a loss after tax (PAT) of Rs. -6.08 crores over the last nine months, a decline of 51.32% year-on-year. Net sales for the latest six months stood at Rs.6.32 crores, down 48.66% compared to the previous period, underscoring ongoing revenue struggles.
The stock price reacted negatively to these results, closing at Rs.24.56, down 1.60% on the day, despite the Sensex gaining 0.13%. This divergence emphasised the market’s cautious stance on the company’s deteriorating fundamentals and weak profitability metrics.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
12 February 2026: New 52-Week Low of Rs.22.99 Amid Continued Weak Performance
The downtrend intensified on 12 Feb 2026 as Medi Caps Ltd’s stock fell to a new 52-week low of Rs.22.99, down 6.47% on the day. The stock opened higher at Rs.25.10 but retreated sharply, closing near the day’s low. This marked the second consecutive day of decline, with the stock losing 7.89% over the two-day period.
Meanwhile, the Sensex declined marginally by 0.56%, closing at 37,049.40, highlighting the stock’s underperformance relative to the broader market. The company’s financial metrics remained weak, with negative EBITDA, low cash reserves of Rs.0.09 crores, and an average EBIT to interest ratio of -1.38, indicating difficulties in servicing debt obligations.
13 February 2026: Further Decline to Rs.22 Amidst Sustained Downtrend
On the final trading day of the week, 13 Feb 2026, Medi Caps Ltd’s stock declined further to Rs.22, marking yet another 52-week low and a 4.90% drop on the day. This brought the stock’s cumulative decline over the last three trading sessions to nearly 10%. The stock remained below all major moving averages, signalling persistent bearish momentum.
The Sensex also declined by 1.40% to 36,532.48, but the stock’s fall was considerably steeper, underscoring company-specific challenges. The company’s return on equity remained subdued at 1.46%, and liquidity constraints persisted with minimal cash and cash equivalents. Despite the sector’s relative resilience, Medi Caps Ltd’s stock continued to lag behind peers and indices.
Holding Medi Caps Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Medi Caps Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.24.50 | +0.70% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.24.96 | +1.88% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.24.56 | -1.60% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.23.25 | -5.33% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.22.18 | -4.60% | 36,532.48 | -1.40% |
Key Takeaways
Financial Deterioration: The company’s quarterly and nine-month results reveal deepening losses with PAT declining by over 51% year-on-year and net sales contracting nearly 49%, signalling ongoing operational challenges.
Liquidity and Debt Concerns: Cash reserves remain critically low at Rs.0.09 crores, while the EBIT to interest coverage ratio is negative, indicating difficulties in servicing debt obligations and raising concerns about financial stability.
Persistent Downtrend: The stock has hit multiple 52-week lows during the week, closing below all major moving averages, reflecting sustained bearish momentum and weak investor sentiment.
Market Underperformance: Medi Caps Ltd’s stock fell 8.84% over the week, significantly underperforming the Sensex’s 0.54% decline, highlighting company-specific issues rather than broader market weakness.
Conclusion
Medi Caps Ltd’s stock performance over the week ending 13 Feb 2026 underscores a challenging period marked by deteriorating financial results, liquidity constraints, and sustained bearish momentum. Despite a broadly resilient market environment, the stock’s sharp decline and multiple 52-week lows reflect deep-rooted operational and financial difficulties. The company’s downgrade to a Strong Sell mojo grade by MarketsMOJO further emphasises the cautious outlook based on current fundamentals. Investors should note the persistent underperformance relative to the Sensex and sector benchmarks, as well as the company’s weak profitability and debt servicing capacity.
Unlock special upgrade rates for a limited period. Start Saving Now →
